Sartorius Aktiengesellschaft Stock Current Liabilities
| SARTF Stock | USD 184.27 15.93 7.96% |
Fundamental analysis of Sartorius Aktiengesellscha allows traders to better anticipate movements in Sartorius Aktiengesellscha's stock price by examining its financial health and performance throughout various phases of its business cycle.
Sartorius |
Sartorius Aktiengesellschaft Company Current Liabilities Analysis
Sartorius Aktiengesellscha's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Sartorius Aktiengesellscha Current Liabilities | 306 M |
Most of Sartorius Aktiengesellscha's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sartorius Aktiengesellschaft is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Sartorius Aktiengesellschaft has a Current Liabilities of 306 M. This is 82.54% lower than that of the Healthcare sector and 45.14% lower than that of the Medical Instruments & Supplies industry. The current liabilities for all United States stocks is 96.13% higher than that of the company.
Sartorius Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sartorius Aktiengesellscha's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sartorius Aktiengesellscha could also be used in its relative valuation, which is a method of valuing Sartorius Aktiengesellscha by comparing valuation metrics of similar companies.Sartorius Aktiengesellscha is currently under evaluation in current liabilities category among its peers.
Sartorius Fundamentals
| Return On Equity | 0.34 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 27.76 B | |||
| Shares Outstanding | 34.23 M | |||
| Shares Owned By Insiders | 84.78 % | |||
| Shares Owned By Institutions | 3.73 % | |||
| Price To Earning | 58.19 X | |||
| Price To Book | 11.12 X | |||
| Price To Sales | 6.33 X | |||
| Revenue | 3.45 B | |||
| Gross Profit | 1.84 B | |||
| EBITDA | 926.52 M | |||
| Net Income | 318.89 M | |||
| Cash And Equivalents | 264.2 M | |||
| Cash Per Share | 3.86 X | |||
| Total Debt | 1.65 B | |||
| Debt To Equity | 1.03 % | |||
| Current Ratio | 0.96 X | |||
| Book Value Per Share | 27.44 X | |||
| Cash Flow From Operations | 865.81 M | |||
| Earnings Per Share | 8.43 X | |||
| Price To Earnings To Growth | 2.07 X | |||
| Number Of Employees | 16.04 K | |||
| Beta | 0.64 | |||
| Market Capitalization | 29.22 B | |||
| Total Asset | 5.7 B | |||
| Working Capital | 282 M | |||
| Current Asset | 588 M | |||
| Current Liabilities | 306 M | |||
| Z Score | 10.2 | |||
| Annual Yield | 0 % | |||
| Net Asset | 5.7 B | |||
| Last Dividend Paid | 1.25 |
About Sartorius Aktiengesellscha Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sartorius Aktiengesellschaft's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sartorius Aktiengesellscha using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sartorius Aktiengesellschaft based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in Sartorius Pink Sheet
Sartorius Aktiengesellscha financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Aktiengesellscha security.